The expanding demand for controlled immunological research and therapeutic creation has spurred significant progress in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression platforms, including microbial hosts, higher cell lines, and insect expres